Artificial intelligence extension of the OSCAR‐IB criteria
Abstract Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big data in neurology is optical coherence tomogra...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Annals of Clinical and Translational Neurology |
Online Access: | https://doi.org/10.1002/acn3.51320 |
id |
doaj-ccdac27211654d478033fb88993a9e04 |
---|---|
record_format |
Article |
spelling |
doaj-ccdac27211654d478033fb88993a9e042021-07-16T05:45:50ZengWileyAnnals of Clinical and Translational Neurology2328-95032021-07-01871528154210.1002/acn3.51320Artificial intelligence extension of the OSCAR‐IB criteriaAxel Petzold0Philipp Albrecht1Laura Balcer2Erik Bekkers3Alexander U. Brandt4Peter A. Calabresi5Orla Galvin Deborah6Jennifer S. Graves7Ari Green8Pearse A Keane9Jenny A. Nij Bijvank10Josemir W. Sander11Friedemann Paul12Shiv Saidha13Pablo Villoslada14Siegfried K Wagner15E. Ann Yeh16the IMSVISUAL, ERN‐EYE ConsortiumMoorfields Eye Hospital City Road, The National Hospital for Neurology and Neurosurgery Queen Square UCL Queen Square Institute of Neurology London UKDepartment of Neurology Medical Faculty Heinrich‐Heine University Düsseldorf GermanyDepartments of Neurology Population Health and Ophthalmology NYU Grossman School of Medicine New York USAAMLAB Amsterdam The NetherlandsDepartment of Neurology University of California Irvine California USADepartment of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USARetina International Dublin IrelandDepartment of Neurosciences UC San Diego California USADepartment of Neurology University of California San Francisco San Francisco California USAMoorfields Eye Hospital City Road, The National Hospital for Neurology and Neurosurgery Queen Square UCL Queen Square Institute of Neurology London UKNeuro‐ophthalmology Expert Center Amsterdam UMC The NetherlandsNIHR UCL Hospitals Biomedical Research Centre UCL Queen Square Institute of Neurology London UKExperimental and Clinical Research Center Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin corporate member of Freie Universität Berlin Humboldt‐Universität zu Berlin, and Berlin Institute of Health GermanyDepartment of Neurology Johns Hopkins University School of Medicine Baltimore Maryland USAInstitut d’Investigacion Biomediques August Pi Sunyer (DIBAPS) and Hospital Clinic University of Barcelona Barcelona SpainMoorfields Eye Hospital City Road, The National Hospital for Neurology and Neurosurgery Queen Square UCL Queen Square Institute of Neurology London UKDivision of Neurology Department of Pediatrics Hospital for Sick Children Division of Neurosciences and Mental Health SickKids Research Institute University of Toronto CanadaAbstract Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big data in neurology is optical coherence tomography (OCT). We highlight that OCT changes observed in the retina, as a window to the brain, are small, requiring rigorous quality control pipelines. There are existing tools for this purpose. Firstly, there are human‐led validated consensus quality control criteria (OSCAR‐IB) for OCT. Secondly, these criteria are embedded into OCT reporting guidelines (APOSTEL). The use of the described annotation of failed OCT scans advances machine learning. This is illustrated through the present review of the advantages and disadvantages of AI‐based applications to OCT data. The neurological conditions reviewed here for the use of big data include Alzheimer disease, stroke, multiple sclerosis (MS), Parkinson disease, and epilepsy. It is noted that while big data is relevant for AI, ownership is complex. For this reason, we also reached out to involve representatives from patient organizations and the public domain in addition to clinical and research centers. The evidence reviewed can be grouped in a five‐point expansion of the OSCAR‐IB criteria to embrace AI (OSCAR‐AI). The review concludes by specific recommendations on how this can be achieved practically and in compliance with existing guidelines.https://doi.org/10.1002/acn3.51320 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Axel Petzold Philipp Albrecht Laura Balcer Erik Bekkers Alexander U. Brandt Peter A. Calabresi Orla Galvin Deborah Jennifer S. Graves Ari Green Pearse A Keane Jenny A. Nij Bijvank Josemir W. Sander Friedemann Paul Shiv Saidha Pablo Villoslada Siegfried K Wagner E. Ann Yeh the IMSVISUAL, ERN‐EYE Consortium |
spellingShingle |
Axel Petzold Philipp Albrecht Laura Balcer Erik Bekkers Alexander U. Brandt Peter A. Calabresi Orla Galvin Deborah Jennifer S. Graves Ari Green Pearse A Keane Jenny A. Nij Bijvank Josemir W. Sander Friedemann Paul Shiv Saidha Pablo Villoslada Siegfried K Wagner E. Ann Yeh the IMSVISUAL, ERN‐EYE Consortium Artificial intelligence extension of the OSCAR‐IB criteria Annals of Clinical and Translational Neurology |
author_facet |
Axel Petzold Philipp Albrecht Laura Balcer Erik Bekkers Alexander U. Brandt Peter A. Calabresi Orla Galvin Deborah Jennifer S. Graves Ari Green Pearse A Keane Jenny A. Nij Bijvank Josemir W. Sander Friedemann Paul Shiv Saidha Pablo Villoslada Siegfried K Wagner E. Ann Yeh the IMSVISUAL, ERN‐EYE Consortium |
author_sort |
Axel Petzold |
title |
Artificial intelligence extension of the OSCAR‐IB criteria |
title_short |
Artificial intelligence extension of the OSCAR‐IB criteria |
title_full |
Artificial intelligence extension of the OSCAR‐IB criteria |
title_fullStr |
Artificial intelligence extension of the OSCAR‐IB criteria |
title_full_unstemmed |
Artificial intelligence extension of the OSCAR‐IB criteria |
title_sort |
artificial intelligence extension of the oscar‐ib criteria |
publisher |
Wiley |
series |
Annals of Clinical and Translational Neurology |
issn |
2328-9503 |
publishDate |
2021-07-01 |
description |
Abstract Artificial intelligence (AI)‐based diagnostic algorithms have achieved ambitious aims through automated image pattern recognition. For neurological disorders, this includes neurodegeneration and inflammation. Scalable imaging technology for big data in neurology is optical coherence tomography (OCT). We highlight that OCT changes observed in the retina, as a window to the brain, are small, requiring rigorous quality control pipelines. There are existing tools for this purpose. Firstly, there are human‐led validated consensus quality control criteria (OSCAR‐IB) for OCT. Secondly, these criteria are embedded into OCT reporting guidelines (APOSTEL). The use of the described annotation of failed OCT scans advances machine learning. This is illustrated through the present review of the advantages and disadvantages of AI‐based applications to OCT data. The neurological conditions reviewed here for the use of big data include Alzheimer disease, stroke, multiple sclerosis (MS), Parkinson disease, and epilepsy. It is noted that while big data is relevant for AI, ownership is complex. For this reason, we also reached out to involve representatives from patient organizations and the public domain in addition to clinical and research centers. The evidence reviewed can be grouped in a five‐point expansion of the OSCAR‐IB criteria to embrace AI (OSCAR‐AI). The review concludes by specific recommendations on how this can be achieved practically and in compliance with existing guidelines. |
url |
https://doi.org/10.1002/acn3.51320 |
work_keys_str_mv |
AT axelpetzold artificialintelligenceextensionoftheoscaribcriteria AT philippalbrecht artificialintelligenceextensionoftheoscaribcriteria AT laurabalcer artificialintelligenceextensionoftheoscaribcriteria AT erikbekkers artificialintelligenceextensionoftheoscaribcriteria AT alexanderubrandt artificialintelligenceextensionoftheoscaribcriteria AT peteracalabresi artificialintelligenceextensionoftheoscaribcriteria AT orlagalvindeborah artificialintelligenceextensionoftheoscaribcriteria AT jennifersgraves artificialintelligenceextensionoftheoscaribcriteria AT arigreen artificialintelligenceextensionoftheoscaribcriteria AT pearseakeane artificialintelligenceextensionoftheoscaribcriteria AT jennyanijbijvank artificialintelligenceextensionoftheoscaribcriteria AT josemirwsander artificialintelligenceextensionoftheoscaribcriteria AT friedemannpaul artificialintelligenceextensionoftheoscaribcriteria AT shivsaidha artificialintelligenceextensionoftheoscaribcriteria AT pablovilloslada artificialintelligenceextensionoftheoscaribcriteria AT siegfriedkwagner artificialintelligenceextensionoftheoscaribcriteria AT eannyeh artificialintelligenceextensionoftheoscaribcriteria AT theimsvisualerneyeconsortium artificialintelligenceextensionoftheoscaribcriteria |
_version_ |
1721297902860500992 |